Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Inv. presentation
Quarterly results
Director departure

Roka BioScience, Inc. (ROKA) Create: Alert

All | News | Filings
Date FiledTypeDescription
01/26/2018 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
01/09/2018 EFFECT Form EFFECT - Notice of Effectiveness:
01/09/2018 EFFECT Form EFFECT - Notice of Effectiveness:
01/09/2018 EFFECT Form EFFECT - Notice of Effectiveness:
01/04/2018 8-K Quarterly results
12/28/2017 POS AM Form POS AM - Post-Effective amendments for registration statement:
12/28/2017 POS AM Form POS AM - Post-Effective amendments for registration statement:
12/20/2017 8-K/A Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and...
12/19/2017 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and...
Docs: "Sorrento Tech, Inc. Announces Voluntary Delisting from Nasdaq and Closing of its Stock Transfer Books"
12/19/2017 25 Form 25 - Notification of the removal from listing and registration of matured, redeemed or retired securities:
11/17/2017 8-K Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Financial Statements and Exhibits
Docs: "Lease Termination Agreement, by and between Sorrento Tech, Inc. and CIO Sorrento Mesa, LLC"
11/13/2017 10-Q Quarterly Report for the period ended September 30, 2017
11/07/2017 8-K Financial Statements and Exhibits
Docs: "The unaudited pro forma condensed combined statement of operations for the six months ended June 30, 2017 and for the fiscal years ended December 31, 2016 and 2015, the unaudited pro forma condensed combined balance sheet as of June 30, 2017, and the notes related thereto"
11/02/2017 GN Analysis: Positioning to Benefit within Tandem Diabetes Care, CASI Pharmaceuticals, SAExploration, Roka Bioscience, VirnetX, and PhaseRx – Research Highlights Growth, Revenue, and Consolidated Results
11/01/2017 8-K Completion of Acquisition or Disposition of Assets, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year,...
Docs: "Certificate of Amendment to the Company’s Seventh Amended and Restated Certificate of Incorporation"
10/26/2017 8-K Submission of Matters to a Vote of Security Holders, Other Events
10/23/2017 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
10/10/2017 SC 13D Painter Edward H reports a 6.8% stake in Roka Bioscience, Inc
10/05/2017 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
10/03/2017 DEF 14A Form DEF 14A - Other definitive proxy statements:
10/03/2017 8-K Resignation/termination of a director
10/02/2017 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
09/29/2017 8-K Quarterly results
09/28/2017 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
09/27/2017 10-Q/A Quarterly Report for the period ended June 30, 2017 [amend]
09/27/2017 10-Q/A Quarterly Report for the period ended March 31, 2017 [amend]
09/27/2017 PRER14A Form PRER14A - Preliminary Proxy Soliciting materials:
09/19/2017 8-K Quarterly results
09/11/2017 SC 13G Shansab Tamim reports a 4.7% stake in ROKA BIOSCIENCE, INC.
08/29/2017 PRE 14A Form PRE 14A - Other preliminary proxy statements:
08/23/2017 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
08/18/2017 10-Q Quarterly Report for the period ended June 30, 2017
08/17/2017 8-K Quarterly results
08/14/2017 NT 10-Q Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB:
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy